CompaniesByCap
TGTX
TG Therapeutics, Inc. (TGTX)
NASDAQ · Healthcare

TG Therapeutics, Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue616.3M329.0M233.7M2.8M6.7M152,000152,000152,000152,000152,000
Gross Profit515.6M290.5M219.5M2.5M5.9M
Profitability
Operating Income123.3M41.9M20.6M-218.3M-344.8M-273.6M-169.1M-174.4M-118.7M-79.0M
EBITDA123.4M42.0M20.8M-218.0M-344.5M
Net Income447.2M23.4M12.7M-223.8M-348.1M
Per Share Data
EPS (diluted)$2.77$0.15$0.09$-1.65$-2.63$-2.42
Shares Outstanding (dil.)161M160M149M135M132M115M109M84M73M57M

TG Therapeutics, Inc. Income Statement — FAQ

TG Therapeutics, Inc. (TGTX) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TGTX's income statement history?

The chart and table above show TG Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.